ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway

Diao, Hongtao; Cheng, Jiawen; Huang, Xueying; Huang, Bingying; Shao, Xiaoqi; Zhao, Jingjing; Lan, Dingming; Zhu, Qing; Yan, Meiling; Zhang, Yue; Rong, Xianglu; Guo, Jiao*广东药学院
Journal of Ethnopharmacology2022-7-15DOI: 10.1016/j.jep.2022.115261
9被引2阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Fufang Zhenzhu Tiaozhi (FTZ) is a traditional Chinese herbal prescription that has been used to treat dyslipidemia, nonalcoholic fatty liver disease, atherosclerosis, diabetes and its compli-cations in the clinic for almost ten years. Endothelial-mesenchymal transition (EndMT) is the key driver of atherosclerosis. However, the effects of FTZ on endothelial dysfunction and EndMT remain unknown. @@@ Aim of the study: To evaluate the therapeutic effects of FTZ against EndMT and the underlying mechanisms. @@@ Materials and methods: An in vivo model of atherosclerosis was established by feeding ApoE(-/-) mice with a high -fat diet (HFD). The body weight, lipid levels, plaque area, lipid deposition and EndMT were evaluated using standard assays 12 weeks after intragastric administration of FTZ and simvastatin. Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low-density lipoprotein (ox-LDL) to simulate EndMT in vitro. The degree of EndMT was assessed after treating the cells with FTZ or transfection with si-Akt1. The expression levels of genes involved in EndMT were quantified by real-time PCR or western blotting. @@@ Results: FTZ ameliorated dyslipidemia and endothelial dysfunction in the atherosclerotic mice. In addition, FTZ reduced body weight and the total cholesterol, triglycerides and low-density lipoprotein levels, and increased that of high-density lipoproteins. FTZ also upregulated the expression of endothelial markers (CD31 and VE-cadherin) and decreased that of mesenchymal markers (alpha-SMA and FSP1), indicating that it inhibits EndMT. Knocking down Akt1 exacerbated EndMT and reversed the therapeutic effect of FTZ. @@@ Conclusion: FTZ delayed atherosclerosis by inhibiting EndMT via the Akt1/beta-catenin pathway.

学科与关键词

关键词
Fufang-Zhenzhu-Tiaozhi (FTZ)AtherosclerosisEndMTAkt1beta-catenin
相关
加载中…
  • Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA
    Zhang, Yue; Wang, Ruonan; Tan, Huiling; Wu, Kaili; Hu, Yaju; Diao, Hongtao; Wang, Dongwei; Tang, Xinyuan; Leng, Mingyang; Li, Xu; Cai, Zhenlu; Luo, Duosheng; Shao, Xiaoqi; Yan, Meiling; Chen, Yingyu; Rong, Xianglu; Guo, Jiao*Journal of Ethnopharmacology, 2023, 317: 116766.被引 1
  • Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs
    Wang, Lexun; Zhang, Dongxing; Zhan, Wenjing; Zeng, Zhihuan; Yin, Jianying; Wang, Ke; Wang, Hong; Song, Lixia; Gu, Zhanhui; Guo, Caijuan; Zhong, Qin; Wang, Weixuan; Rong, Xianglu; Bei, Weijian; Guo, JiaoBiomedicine and Pharmacotherapy, 2022, 156: 113831.被引 2
  • The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway
    Zhang, Yue; Wang, Dongwei; Wu, Kaili; Shao, Xiaoqi; Diao, Hongtao; Wang, Zhiying; Sun, Mengxian; Huang, Xueying; Li, Yun; Tang, Xinyuan; Yan, Meiling; Guo, Jiao*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5642307.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-07-15
卷期
第 293 卷
页码
115261
DOI
10.1016/j.jep.2022.115261
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Center for Drug Research and Development of Guangdong Pharmaceutical University

作者

  • D

    Diao, Hongtao (第一作者)

    guangdong pharmaceut univ

  • C

    Cheng, Jiawen

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • H

    Huang, Xueying

    guangdong pharmaceut univ

  • H

    Huang, Bingying

    guangdong pharmaceut univ

  • S

    Shao, Xiaoqi

    guangdong pharmaceut univ

  • Z

    Zhao, Jingjing

    guangdong pharmaceut univ

  • L

    Lan, Dingming

    guangdong pharmaceut univ

  • Z

    Zhu, Qing

    guangdong pharmaceut univ

  • Y

    Yan, Meiling

    guangdong pharmaceut univ

  • Z

    Zhang, Yue

    guangdong pharmaceut univ

  • R

    Rong, Xianglu

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417